BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10427707)

  • 1. Tyrosine-83 of human renin contributes to biphasic pH dependence of the renin-angiotensinogen reaction.
    Nasir UM; Suzuki F; Nagai T; Nakagawa T; Nakamura Y
    Biosci Biotechnol Biochem; 1999 Jun; 63(6):1143-5. PubMed ID: 10427707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ser84 of human renin contributes to the biphasic pH dependence of the renin-angiotensinogen reaction.
    Iwata H; Nakagawa T; Nishiuchi K; Hiratsuka T; Satou R; Yoshioka Y; Fukui Y; Suzuki F; Nakamura Y
    Biosci Biotechnol Biochem; 2007 May; 71(5):1279-85. PubMed ID: 17485830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coexistence of Ser84 in renin and His13 in angiotensinogen brings a pH profile of two separate peaks to the reaction of human renin and sheep angiotensinogen.
    Iwata H; Nakagawa T; Yoshioka Y; Kagei K; Imada K; Nakane C; Fujita H; Suzuki F; Nakamura Y
    Biosci Biotechnol Biochem; 2008 Jan; 72(1):179-85. PubMed ID: 18175911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two peaks in pH dependence of renin-angiotensinogen reaction.
    Nasir UM; Takahashi K; Nagai T; Nakagawa T; Suzuki F; Nakamura Y
    Biosci Biotechnol Biochem; 1998 Feb; 62(2):338-40. PubMed ID: 9532792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of His9 (P2 subsite) and His13 (P3' subsite) in angiotensinogen for catalytic reaction of renin.
    Nabi AH; Uddin MN; Nakagawa T; Orihashi T; Ebihara A; Iwasawa A; Nakamura Y; Suzuki F
    Int J Mol Med; 2005 Jul; 16(1):103-7. PubMed ID: 15942685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
    Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
    Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-dependent inactivation and reactivation of recombinant sheep angiotensinogen.
    Nagase M; Suzuki F; Takahashi A; Fujimori M; Sawai Y; Nakamura Y
    Biosci Biotechnol Biochem; 1995 Apr; 59(4):765-6. PubMed ID: 7772849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycosylation of the residue at position 14 in ovine angiotensinogen on the human renin reaction.
    Inui Y; Orihashi T; Nakagawa T; Ebihara A; Suzuki F; Nakamura Y
    Biosci Biotechnol Biochem; 1998 Aug; 62(8):1612-4. PubMed ID: 9757569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
    Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
    J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
    Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
    Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli-based production of recombinant ovine angiotensinogen and its characterization as a renin substrate.
    Yamashita S; Shibata N; Boku-Ikeda A; Abe E; Inayama A; Yamaguchi T; Higuma A; Inagaki K; Tsuyuzaki T; Iwamoto S; Ohno S; Yokogawa T; Nishikawa K; Biswas KB; Nabi AH; Nakagawa T; Suzuki F; Ebihara A
    BMC Biotechnol; 2016 Apr; 16():33. PubMed ID: 27052373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino-acid residues on the C-terminal side of the cleavage site of angiotensinogen influence the species specificity of reaction with renin.
    Burton J; Quinn T
    Biochim Biophys Acta; 1988 Jan; 952(1):8-12. PubMed ID: 3275468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen.
    Tokita Y; Franco-Saenz R; Reimann EM; Mulrow PJ
    Hypertension; 1994 Apr; 23(4):422-7. PubMed ID: 8144210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of human angiotensinogen (1-17) containing one of the putative glycosylation binding sites and its hydrolysis by human renin and porcine pepsin.
    Hirata IY; Boschcov P; Oliveira MC; Juliano MA; Miranda A; Chagas JR; Tsuboi S; Okada Y; Juliano L
    Int J Pept Protein Res; 1991 Oct; 38(4):298-307. PubMed ID: 1797705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant human renin: kinetics, pH-stability, and peptidomimetic inhibitor binding.
    Holzman TF; Chung CC; Edalji R; Egan DA; Martin M; Gubbins EJ; Krafft GA; Wang GT; Thomas AM; Rosenberg SH
    J Protein Chem; 1991 Oct; 10(5):553-63. PubMed ID: 1799412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity of recombinant human renal renin: effect of histidine in the P2 subsite on pH dependence.
    Green DW; Aykent S; Gierse JK; Zupec ME
    Biochemistry; 1990 Mar; 29(12):3126-33. PubMed ID: 2186807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative enzymatic studies of human renin acting on pure natural or synthetic substrates.
    Cumin F; Le-Nguyen D; Castro B; Menard J; Corvol P
    Biochim Biophys Acta; 1987 May; 913(1):10-9. PubMed ID: 3555621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of inactive renin from human kidney and plasma. Evidence of a renal source of circulating inactive renin.
    Hsueh WA; Carlson EJ; Dzau VJ
    J Clin Invest; 1983 Mar; 71(3):506-17. PubMed ID: 6338039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.
    Sawyer TK; Hester JB; Schostarez HJ; Thaisrivongs S; Bundy GL; Liu L; Bradford VS; De Vaux AE; Staples DJ; Maggiora LL
    Adv Exp Med Biol; 1991; 306():307-23. PubMed ID: 1812721
    [No Abstract]   [Full Text] [Related]  

  • 20. Is angiotensinogen a renin inhibitor and not the substrate for renin?
    Poulsen K; Jacobsen J
    J Hypertens; 1986 Feb; 4(1):65-9. PubMed ID: 3514748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.